Clinical Trials Browser

Phase 1 × INDUSTRY × HuMax-IL8 × Clear all

NCT02536469 2017-02-03

HuMax-IL8 (Interleukin8) in Patients With Advanced Malignant Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor